Search criteria | ||||
Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy | ||||
Colombo GL, Heiman F, Peduto I | ||||
Colombo GL: CEFAT - Department of Drug Sciences, University of Pavia, Pavia, Italy. Peduto I, Heiman F: IQVIA Solutions Italy S.r.l., Milan, Italy, | ||||
Ther Clin Risk Manag. 2021 Apr 21;17:345-356. doi: 10.2147/TCRM.S301005 |
||||
, Article | ||||
, Italy | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072261/pdf/tcrm-17-345.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Overactive bladder | 2021 | English | , Clinical setting: Primary care, Cost of illness | |
Impact of overactive bladder symptoms on work activity: the ACTIVHA study | ||||
Rapariz M1, Mora AM2, Roset M3. | ||||
1, Servicio de Urología, Hospital de Gran Canaria Dr. Negrín, Gran Canaria, España 2,Astellas Pharma, Madrid, España 3, Real World Insights, QuintilesIMS, Barcelona, España | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2018 | Spanish | ||
The Economic Impact of Overactive Bladder Syndrome in Six Western Countries. | ||||
Irwin DE1, Mungapen L2, Milsom I3, Kopp Z4, Reeves P2, Kelleher C5 | ||||
1Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, US 2 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 3 Department of Obstetrics & Gynaecology, Sahlgrenska Academy at the University of Gothenburg, Sweden 4 Pfizer Inc., New York, USA, , 5 Department of Obstetrics and Gynaecology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK | ||||
British Journal of Urology International (BJU International), 103(2):202-209 |
||||
, Article | ||||
, Canada, Germany, Italy, Spain, Sweden, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19278532?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1 | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2009 | English | , Budget impact | |
The Toviaz YourWay Plan: A multidimensional program for managing overactive bladder. | ||||
Taylor P1, Trocio J2, Schabert VF3, Golberg EL3, Bavendam T2, Brubaker L4 | ||||
1 Emory University, Atlanta, GA, USA 2 Pfizer Inc., New York, NY, USA 3 IMS Health, Inc., Falls Church, VA, USA 4 Loyola University, Maywood, IL, USA | ||||
American Urogynecologic Society 30th Annual Scientific Meeting, 2009, September, Hollywood, FL, USA |
||||
, Oral presentation | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2009 | English | , Review | |
Challenges for managing overactive bladder and guidance for patient support. | ||||
Schabert VF1, Bavendam T2, GoldbergEL1, Trocio JN2, Brubaker L3 | ||||
1 IMS Health, Inc., Falls Church, VA, USA 2 Pfizer, Inc., New York, NY, USA 3 Loyola University, Chicago, IL, USA | ||||
American Journal of Managed Care, 2009, 15(4 Suppl): S118-122 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2009 | English | , Survey research | |
Dvelopment of a multidimensional approach to managing overactive bladder. | ||||
Taylor P1, Goldberg EL2, Schabert VF2, Trocio J3, Bavendam T3 | ||||
1 Emory University, Atlanta, GA, USA 2 IMS Health, Inc., Falls Church, VA, USA 3 Pfizer Inc., New York, NY, USA | ||||
American Academy of Physician Assistants 37th Annual Conference, 2009, May 23-28, San Diego, CA, USA |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2009 | English | , Survey research | |
Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder. | ||||
Pelletier EM1, Vats V2, Clemens JQ3 | ||||
1IMS Health, Watertown, MA, USA, 2Pfizer Inc., New York, NY, USA, 3University of Michigan, Ann Arbor, MI, USA | ||||
American Journal of Managed Care, 2009, 15(Suppl 4): S108-S114 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2009 | English | , Compliance, Cost analysis | |
Patterns and Predictors of Overactive Bladder-specific Quality of Life. | ||||
Benner J1, Brubaker L, Bavendam T, Fanning F, Goldberg E2, Trocio J3, Jumadilova Z | ||||
1 Formerly of IMS Health, Falls Church, VA, US 2 IMS Health, Falls Church, VA 3 Pfizer, New York, NY, US | ||||
Journal of Pelvic Medicine & Surgery;2007 Sept/Oct;13(5):302-303(#91P) |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2008 | English | , Quality of life | |
“Overactive bladder symptom bother is more prevalent in men than women at older ages.” | ||||
Albo M, Rovner E, Mullins C, Becker R, Jumadilova Z, Benner J. | ||||
American Urology Association Western Section Meeting, October 2006 |
||||
, Oral presentation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2006 | English | , Epidemiological study | |
“Patient-Reported Reasons for Discontinuing Overactive Bladder (OAB) Medications.” | ||||
Brubaker L, Nichol M, Fanning T, Becker R, Jumadilova Z, Benner J | ||||
Annual International Continence Society Meeting, November 2006. |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2006 | English | ||
“Factors Associated with Care Seeking for Overactive Bladder Symptoms,” | ||||
Nichol M, Brubaker L, Fanning T, Hussein M, Becker R, Benner J, Jumadilova Z, | ||||
11th Annual Meeting of the International Society of Pharmacoeconomics and Outcomes Research, June 2006. |
||||
, Oral presentation | ||||
Condition | Year | Language | Analysis type | |
, Overactive bladder | 2006 | English | ||